U.S. Markets closed

ThromboGenics NV (TBGNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.800.00 (0.00%)
At close: 9:31AM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 5135.98M
Enterprise Value 3N/A
Trailing P/E -1.99
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)16.27
Price/Book (mrq)1.09
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Dec 31, 2016
Profit Margin 0.00%
Operating Margin (ttm)-482.10%
Management Effectiveness
Return on Assets (ttm)-14.24%
Return on Equity (ttm)-43.13%
Income Statement
Revenue (ttm)8.36M
Revenue Per Share (ttm)0.23
Quarterly Revenue Growth (yoy)-40.10%
Gross Profit (ttm)N/A
EBITDA -31.24M
Net Income Avi to Common (ttm)-70.94M
Diluted EPS (ttm)-1.91
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)94.17M
Total Cash Per Share (mrq)2.61
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.76
Book Value Per Share (mrq)3.48
Cash Flow Statement
Operating Cash Flow (ttm)-23.89M
Levered Free Cash Flow (ttm)-9.83M

Trading Information

Stock Price History
Beta N/A
52-Week Change 37.04%
S&P500 52-Week Change 311.33%
52 Week High 33.95
52 Week Low 30.00
50-Day Moving Average 33.56
200-Day Moving Average 33.53
Share Statistics
Avg Vol (3 month) 325
Avg Vol (10 day) 3N/A
Shares Outstanding 536.09M
Float 30.41M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A